Thomas Seck in

Thomas Seck

Inquirer · DISC type dc
Senior Vice President Head of Clinical Development Cardiometabolic Health at Eli Lilly and Company
📍 New York City Metropolitan Area, United States

Professional overview including current role context, leadership scope, domain focus, and career trajectory to help you understand background relevance before outreach.

Key behavioral and communication insights including interaction style, decision-making tendencies, and motivation drivers to tailor messaging and personalize conversations.

Business priorities, areas of interest, and practical outreach recommendations that can improve conversion quality for this professional.

Login to view overviewLogin to view overview
Experience
16 Years
Current Role
Senior Vice President Head of Clinical Development Cardiometabolic Health
Job Level
Leadership
Location
New York City Metropolitan Area, United States
Personality Overview

How Thomas shows up

ROI Conscious
Upfront
Judgemental

They respond well to confident salespeople. They care equally about the product and its potential impact. They can be nudged to make faster decisions by offering what they value.

Priorities

Topics Thomas cares about

Strategic Priorities
Topic insights and context to help personalize outreach and discovery conversations.
Login to view topicsLogin to view topics
Career

Work history

2-2026
Senior Vice President Head of Clinical Development Cardiometabolic Health
Eli Lilly and Company
11-2022 - 2-2026
Senior Vice President, Head of Global Regulatory Affairs
Boehringer Ingelheim
7-2018 - 11-2022
Senior Vice President Medicine & Regulatory Affairs
Boehringer Ingelheim
2-2015 - 7-2018
Vice President Clinical Development and Medical Affairs
Boehringer Ingelheim
9-2006 - 11-2011
Director Clinical Research
Merck
In the press

Media appearances

Media appearances and press coverage highlighting public visibility and thought leadership.
Login to viewLogin to view media
Education
1995 - 2000
Residency and Fellowship Internal Medicine/Endocrinology
Heidelberg University
2003 - 2006
Assistant Professor
Ruhr University Bochum
Social presence
in
Behavioral profile

DISC profile (public)

d

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Eli Lilly and Company Employees

Explore more public profiles from related professionals.

Marc Mazarin
Marc Mazarin
Senior Director of Masterbrand Marketing
Eli Lilly and Company
 Abdullah Almuqaytib, MBA, SHRM-SCP
Abdullah Almuqaytib, MBA, SHRM-SCP
Associate Director - Talent Development
Eli Lilly and Company
 Zerrin Oyan Eter
Zerrin Oyan Eter
Director Corporate Affairs & Pricing, Reimbursement & Access, Türkiye at Eli Lilly
Eli Lilly and Company
 Yasser Altaweel
Yasser Altaweel
Associate Director – Business to Business (B2B) & Strategic Accounts(GCC)
Eli Lilly and Company

More profiles

Discover additional public profiles from our index.

Lykke Hinsch Gylvin, MD EMBA
Lykke Hinsch Gylvin, MD EMBA
Chief Medical Officer and Head of Global Medicine at Boehringer Ingelheim
Boehringer Ingelheim
 Amy Rudolph
Amy Rudolph
Board Member
Thryv Therapeutics Inc.
 Ivan Blanarik
Ivan Blanarik
Global Head of Human Pharma Data& Analytics | SVP
Boehringer Ingelheim
 Sven Meyer
Sven Meyer
Head of Marketing Science
Novartis Pharma
Unlock the full playbookSee exactly how to sell to Thomas. Free, 10 seconds.